Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mCRC × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 296 Neoplasms 250 Carcinoma, Non-Small-Cell Lung 176 Colorectal Neoplasms 150 Prostatic Neoplasms 137 Lung Neoplasms 133 Carcinoma, Hepatocellular 108 Multiple Myeloma 87 Leukemia, Myeloid, Acute 71 Stomach Neoplasms 66 Pancreatic Neoplasms 66 Uterine Cervical Neoplasms 60 Recurrence 60 Neoplasm Metastasis 60 Rectal Neoplasms 59 Squamous Cell Carcinoma of Head and Neck 56 Ovarian Neoplasms 56 Glioblastoma 51 Small Cell Lung Carcinoma 49 Brain Neoplasms 49 Head and Neck Neoplasms 48 Triple Negative Breast Neoplasms 45 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Glioma 42 Endometrial Neoplasms 41 Esophageal Neoplasms 39 Colonic Neoplasms 38 Carcinoma, Renal Cell 37 Urinary Bladder Neoplasms 35 Disease 35

Interventions

trifluridine tipiracil drug combination 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07116577 2025-08-11

Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC

Jinan Central Hospital

Phase 2 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡